Research2Guidance July 29, 2025
Ralf-Gordon Jahns

New R2G report. Integrated drug-app-service bundles are reshaping patient support and commercial strategy in pharma. 3,000 companion apps will help Pharma to generate $20B of incremental revenues by 2029. Selecting the right drugs is essential for the success of companion apps.

Research2Guidance has published its latest market report, “The Rise of Companion Apps: A $20B Opportunity for Pharma by 2029,” providing an in-depth analysis of the emerging digital health segment of companion solutions, integrated drug, app, sensor, and service bundles designed to support patients throughout their treatment journey.

A New Class of Pharma-Digital Integration

Companion apps are evolving into strategic tools for pharmaceutical companies. Unlike generic digital health tools, these apps are tightly coupled with specific drugs or groups of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Apps, Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
Related Articles:
Two App Updates Make The Apple Watch Even Better For Fitness Tracking
The Smart Sleep Alarm Is The Holy Grail Of Health Tracking - 2
A Healthcare Tech Challenge: Cleaning Out the (App) Basement
NHS App to become national channel for the ‘shift to prevention’
Amazon Adds AI Assistant to One Medical App

Share Article